The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yeah,,,I'm unconvinced too... NOT
Bring it on, 80p here we come £1 to £2 run on signed contracts...
Can buy enough at these farcical pence share prices, fill your boots time
Here's to an massive afternoon session going into terrific Tuesday....
The Bulls have this, total no brainer buying at these levels, not even close to perr average yet
Loving g it...
GLA
@Montyfino
Good luck to you, one of the best risk/reward ratios on the market at this level imo
@DO looks like we will get there sooner than expected
As stated volume here today so far amazing and it's only quarter to 11
Bring it on
Welcome L2B.... I bought more at 47p and 47.5p.
LesgO!
Have you taken a position here LB ?
Mobile from lakeside:
Oh bless you got to love the swing traders for trying
Personally I cant be ars@d trying to time swings in the average daily trade pattern, I think some lose sight of the fact that the SP is already on the floor, 80p only takes us to Peer average point
Good luck all genuine holders, expecting a solid run into the close today get us into the mid 50s ready for next leg,
Catch you later
As a side not caught anything yet...lost one in a reed bed
I've just got on board for the ride.
Rodgetrades rather than appear on this BB with a bad attitude for anyone positive, just listen to yesterdays podcast and then you can join us on the positivity trip!
@ Rodgetrades
I back porkys 80p prediction furthermore iafter deal is annouced £1 +
I take it a lot of these sellers never watched the podcast ?
I would not worry about it. No dilution as it stands and no plans as far as we have all been told.
I think they are filling a large order so we should head back up later on.
Consolidate sorry. Still 1/2 asleep!
PM
Any possibility of share conversion in the short-term? Hoping not but if so what ratio do you think it would be?
Thanks for your excellent summary as always
Here are my notes for newbies. As always do your own research as well.
Current market cap only 29 million. This is very, very low for a drug company with several clinical assets.
1) Confirmed VAL 201 deal on track to be announced shortly. Upfront payments, massive milestones and royalties. Appears company will be a very large pharmaceutical which will also bring huge confidence.
2) Focus now on VAL 401 to get a deal here soon. Again expect a decent deal here after 201 deal.
3) Val 301 with Japanese for the last 17 months. Inbound queries from many other pharmaceuticals as confirmed in the meeting a few weeks ago. Deal highly likely here as well.
4) Cash spend is amongst the best on AIM for a drugs company. Strategy to out license future drugs means no risk of large placing. Confirmed no placing planned for some considerable time. Should increase confidence.
5) Confirmed institutional investors are planned with Cenkos on board who will be supporting with this.
6) Lots of projects to be taken that will require low funding to be sold on at pre clinical stage for many millions if they show promise.
7) PYC work is almost complete and would likely have increased the value of our drugs significantly. Also potential findings for other treatments like other cancers or Sepsis.
8) PYC to get 6% of any deal. Cenkos 6% warrants from next year so will want share price to do well. Both on board as strong support.
9) First deal is decades will bring huge confidence here. Key note we only have 65 million shares therefore potential to rise quickly.
10) LIkely 201 will get to market based on lack of side effects, science and success rate so far. Therefore likely to be worth billions.
We have a great CEO and board that cares about the shareholders. No doubt big news will come shortly and the world will be jumping in. Fair price after deal is likely to be £1-£2 pound mark depending on finances and push on from here. I can see Val being many £s in the next year or two with a very large market cap.
I am Keeping those shares because this will very likely be a once in a lifetime investment. The only way is up from this market cap with very, very low risk from here. Remember we are very cheap at the moment at a 26 million market cap and a deal likely to be about to be announced very soon. Strong support at any dips reduces any risk as well so a great investment here and now.